Look at these pore souls. Dr. Scott Walter — a board-certified dermatologist in the Denver area — is raising awareness about ...

Rosacea is thought to affect around 5% of the global population. Credit: Alona Siniehina / Shutterstock. The US’ Food and Drug Administration (FDA) has approved Journey Medical’s Emrosi, the brand ...

An eye doctor has opened up on finding parasitic eye infections in his patients that he says are commonly caused by one ...

(RTTNews) - Journey Medical (DERM) announced the FDA has approved Emrosi for the treatment of inflammatory lesions of rosacea in adults. Emrosi was developed in collaboration with Dr. Reddy's ...

The Food and Drug Administration has approved Emrosi ™ (minocycline hydrochloride extended-release capsules) for the treatment of inflammatory lesions (papules and pustules) of rosacea in adults.

There are a number of treatment options for ED. Initially, a provider may advise the patient to take steps to improve their lifestyle habits, such as increasing their level of physical activity ...

Effective treatment repairs the skin barrier and in doing so reduces inflammation and promotes vasoconstriction. New research finds that topical ferulic acid significantly improves skin lesions and ...

Doctors with Calissa Therapeutics are trying to get the new treatment to come to the U.S., as patients in China have seen positive results.

Dr. Yeu serves as a partner and practicing ophthalmologist at Virginia Eye Consultants, where she will continue her clinical practice. Dr. Yeu has authored hundreds of publications and is a renowned ...

Opens in a new tab or window The FDA approved minocycline hydrochloride extended-release capsules (Emrosi) for treating inflammatory lesions of rosacea in adults, drugmaker Journey Medical ...